KKR to invest in Malaysia’s Avisena Healthcare to support expansion
Trading information for KKR & Co is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., August 23, 2018. REUTERS/Brendan McDermid
Read a summary of this article on FAST.
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
Sept 4 : KKR & Co said on Friday it had agreed to buy a minority stake in Malaysia’s Avisena Healthcare, extending the global investment firm’s push into healthcare.
KKR, which has deployed more than $20 billion in healthcare globally, declined to provide financial details of the Avisena investment when contacted by Reuters.
The investment is expected to support 30-year-old Avisena’s next phase of growth, including the expansion of multi-specialty offerings at its flagship hospitals in Shah Alam and construction of new greenfield hospitals in the Klang Valley, KKR said.
“We believe KKR’s regional healthcare expertise and broader experience will support our efforts to expand our capabilities, strengthen our clinical offering, and deliver high-quality care to more patients,” said Elina Nadia Omar, Avisena Healthcare’s group CEO.
Avisena did not immediately respond to a Reuters request for financial details of the transaction.
Source: Reuters
Sign up for our newsletters
Get the CNA app
Stay updated with notifications for breaking news and our best stories
Get WhatsApp alerts
Join our channel for the top reads for the day on your preferred chat app
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
